Could Weight-Loss surgery tame a common heart rhythm disorder?

NCT ID NCT07027969

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at whether metabolic surgery (like gastric bypass) can reduce the severity of atrial fibrillation (AF), a common heart rhythm problem, in people with obesity. About 100 adults with AF and a BMI between 35 and 65 will be randomly assigned to either surgery or medication. The main goal is to see if surgery lowers the amount of time spent in AF over a year.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Metabolic surgery (Roux-en-Y gastric bypass or sleeve gastrectomy) or anti-obesity medication
What this could lead to
If successful, this could show that weight-loss surgery is an effective way to manage atrial fibrillation in people with obesity, potentially reducing symptoms and the need for other treatments.
What could go wrong
This is a small, early-phase trial with only 100 participants. Surgery carries risks like infection or complications, and the results may not apply to all patients with atrial fibrillation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Cleveland Clinic

    Cleveland, Ohio, 44195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.